Aion Therapeutic Company Top Insiders
| ANTCF Stock | USD 0 0.01 65.83% |
Aion Therapeutic employs about 4 people. The company is managed by 4 executives with a total tenure of roughly 10 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Examination of Aion Therapeutic's management performance can provide insight into the company performance.
| Patricia Purdy Insider Co Sec |
| Graham Simmonds Insider COO CEO |
Aion |
Aion Therapeutic Management Team Effectiveness
The company has return on total asset (ROA) of (0.9607) % which means that it has lost $0.9607 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (4.1726) %, meaning that it generated substantial loss on money invested by shareholders. Aion Therapeutic's management efficiency ratios could be used to measure how well Aion Therapeutic manages its routine affairs as well as how well it operates its assets and liabilities.Aion Therapeutic Workforce Comparison
Aion Therapeutic is rated below average in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is presently estimated at about 9,416. Aion Therapeutic adds roughly 4.0 in number of employees claiming only tiny portion of equities under Drug Manufacturers—Specialty & Generic industry.
Aion Therapeutic Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Aion Therapeutic Price Series Summation is a cross summation of Aion Therapeutic price series and its benchmark/peer.
Aion Therapeutic Notable Stakeholders
An Aion Therapeutic stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Aion Therapeutic often face trade-offs trying to please all of them. Aion Therapeutic's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Aion Therapeutic's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Patricia Purdy | Co Sec | Profile | |
| Graham Simmonds | COO CEO | Profile | |
| FACS FAANS | Medical Director | Profile | |
| Paul Burke | Pres Pharmaceuticals | Profile |
About Aion Therapeutic Management Performance
The success or failure of an entity such as Aion Therapeutic often depends on how effective the management is. Aion Therapeutic management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Aion management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Aion management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Aion Therapeutic Inc., a pharmaceutical company, offer medical cannabis products in Canada. Aion Therapeutic Inc. was incorporated in 2011 and is headquartered in Toronto, Canada. Aion Therapeutic is traded on OTC Exchange in the United States.
Aion Therapeutic Workforce Analysis
Traditionally, organizations such as Aion Therapeutic use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Aion Therapeutic within its industry.Aion Therapeutic Manpower Efficiency
Return on Aion Therapeutic Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 954.6K | |
| Net Loss Per Executive | 954.6K |
Complementary Tools for Aion Pink Sheet analysis
When running Aion Therapeutic's price analysis, check to measure Aion Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aion Therapeutic is operating at the current time. Most of Aion Therapeutic's value examination focuses on studying past and present price action to predict the probability of Aion Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aion Therapeutic's price. Additionally, you may evaluate how the addition of Aion Therapeutic to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |